These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome. Ward JF; Slezak JM; Blute ML; Bergstralh EJ; Zincke H BJU Int; 2005 Apr; 95(6):751-6. PubMed ID: 15794776 [TBL] [Abstract][Full Text] [Related]
3. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients. Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488 [TBL] [Abstract][Full Text] [Related]
4. Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer. Lughezzani G; Gallina A; Larcher A; Briganti A; Capitanio U; Suardi N; Lista G; Abrate A; Sangalli MN; Buffi N; Cestari A; Guazzoni G; Rigatti P; Montorsi F BJU Int; 2013 May; 111(5):723-30. PubMed ID: 22487441 [TBL] [Abstract][Full Text] [Related]
5. Long-term radical prostatectomy outcomes among participants from the European Randomized Study of Screening for Prostate Cancer (ERSPC) Rotterdam. Loeb S; Zhu X; Schroder FH; Roobol MJ BJU Int; 2012 Dec; 110(11):1678-83. PubMed ID: 22998182 [TBL] [Abstract][Full Text] [Related]
6. Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory study. Steuber T; Budäus L; Walz J; Zorn KC; Schlomm T; Chun F; Ahyai S; Fisch M; Sauter G; Huland H; Graefen M; Haese A BJU Int; 2011 Jun; 107(11):1755-61. PubMed ID: 20942833 [TBL] [Abstract][Full Text] [Related]
7. Radical prostatectomy vs radiation therapy and androgen-suppression therapy in high-risk prostate cancer. Westover K; Chen MH; Moul J; Robertson C; Polascik T; Dosoretz D; Katin M; Salenius S; D'Amico AV BJU Int; 2012 Oct; 110(8):1116-21. PubMed ID: 22540922 [TBL] [Abstract][Full Text] [Related]
8. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features. Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249 [TBL] [Abstract][Full Text] [Related]
9. Long-term data on the survival of patients with prostate cancer treated with radical prostatectomy in the prostate-specific antigen era. Isbarn H; Wanner M; Salomon G; Steuber T; Schlomm T; Köllermann J; Sauter G; Haese A; Heinzer H; Huland H; Graefen M BJU Int; 2010 Jul; 106(1):37-43. PubMed ID: 20002667 [TBL] [Abstract][Full Text] [Related]
10. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores. Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457 [TBL] [Abstract][Full Text] [Related]
11. Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy. Bianco FJ; Scardino PT; Stephenson AJ; Diblasio CJ; Fearn PA; Eastham JA Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):448-53. PubMed ID: 15890586 [TBL] [Abstract][Full Text] [Related]
12. Tumour characteristics, oncological and functional outcomes in patients aged ≥ 70 years undergoing radical prostatectomy. Kunz I; Musch M; Roggenbuck U; Klevecka V; Kroepfl D BJU Int; 2013 Mar; 111(3 Pt B):E24-9. PubMed ID: 22947135 [TBL] [Abstract][Full Text] [Related]
13. Short (≤ 1 mm) positive surgical margin and risk of biochemical recurrence after radical prostatectomy. Shikanov S; Marchetti P; Desai V; Razmaria A; Antic T; Al-Ahmadie H; Zagaja G; Eggener S; Brendler C; Shalhav A BJU Int; 2013 Apr; 111(4):559-63. PubMed ID: 22759270 [TBL] [Abstract][Full Text] [Related]
14. Robotic radical prostatectomy as the initial step in multimodal therapy for men with high-risk localised prostate cancer: initial experience of 160 men. Connolly SS; Cathcart PJ; Gilmore P; Kerger M; Crowe H; Peters JS; Murphy DG; Costello AJ BJU Int; 2012 Mar; 109(5):752-9. PubMed ID: 21992472 [TBL] [Abstract][Full Text] [Related]
15. High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy. Savdie R; Horvath LG; Benito RP; Rasiah KK; Haynes AM; Chatfield M; Stricker PD; Turner JJ; Delprado W; Henshall SM; Sutherland RL; Kench JG BJU Int; 2012 Jun; 109(12):1794-800. PubMed ID: 21992536 [TBL] [Abstract][Full Text] [Related]
16. Pathological and biochemical outcomes after radical prostatectomy in men with low-risk prostate cancer meeting the Prostate Cancer International: Active Surveillance criteria. Mitsuzuka K; Narita S; Koie T; Kaiho Y; Tsuchiya N; Yoneyama T; Kakoi N; Kawamura S; Tochigi T; Habuchi T; Ohyama C; Arai Y BJU Int; 2013 May; 111(6):914-20. PubMed ID: 23320782 [TBL] [Abstract][Full Text] [Related]
17. Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens. Swindle P; Eastham JA; Ohori M; Kattan MW; Wheeler T; Maru N; Slawin K; Scardino PT J Urol; 2005 Sep; 174(3):903-7. PubMed ID: 16093984 [TBL] [Abstract][Full Text] [Related]
18. Long-term oncological and continence outcomes after laparoscopic radical prostatectomy: a single-centre experience. Busch J; Stephan C; Herold A; Erber B; Kempkensteffen C; Hinz S; Lein M; Weikert S; Miller K; Magheli A BJU Int; 2012 Dec; 110(11 Pt C):E985-90. PubMed ID: 22672442 [TBL] [Abstract][Full Text] [Related]